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Abstract: Cardiovascular disease (CVD) is still the leading cause of death and disability 
worldwide despite the availability of well-established and effective preventive options. Accurate 
perception of a patient’s risk by both the patient and the doctors is important as this is one of 
the components that determine health-related behavior. Doctors tend to not use cardiovascular 
(CV) risk calculators and underestimate the absolute CV risk of their patients. Patients show 
optimistic bias when considering their own risk and consistently underestimate it. Poor patient 
health literacy and numeracy must be considered when thinking about this problem. Patients 
must possess a reasonably high level of understanding of numerical processes when doctors 
discuss risk, a level that is not possessed by large numbers of the population. In order to 
overcome this barrier, doctors need to utilize various tools including the appropriate use of 
visual aids to accurately communicate risk with their patients. Any intervention has been shown 
to be better than nothing in improving health understanding. The simple process of repeatedly 
conveying risk information to a patient has been shown to improve accuracy of risk perception. 
Doctors need to take responsibility for the accurate assessment and effective communication 
of CV risk in their patients in order to improve patient uptake of cardioprotective lifestyle 
choices and preventive medications.
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Introduction
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide.1 
The primary causative factors of CVD are well-known: 80% of acute myocardial 
infarctions can be attributed to just five modifiable risk factors, smoking, dyslipidemia, 
hypertension, diabetes, and obesity,2 which are also implicated in the increased risk 
of stroke.3 Data from the Framingham Heart Study clearly shows that these CVD 
risk factors do not simply act in isolation.4 In fact, they act synergistically such that 
minor abnormalities in several risk factors combine to produce a high absolute risk 
of disease. It is increasingly being recognized that the management of an individual’s 
risk factors should be based on their overall or “absolute” risk of experiencing a CV 
event rather than on their levels of each risk factor.5 Many tools are now available to 
estimate an individual’s 5- or 10-year risk of coronary disease or CVD,4,6,7 with most 
guidelines for prevention of CVD advising the assessment of absolute risk as a key 
step in managing risk.8–10
Once risk has been assessed, treatment options are established. Diet and exercise,11–13 
smoking cessation,14,15 statin therapy,16 blood-pressure-lowering medication,17 and 
antiplatelet medications18 have all shown clear benefit in lowering CV risk. Despite Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
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there being a clear understanding of how to measure and 
subsequently modify CV risk, risk factors are highly preva-
lent in the general population19 and those who are indicated 
for pharmacological treatment are not necessarily receiving 
it.20–22 Within the broad range of factors that affect uptake of 
information and implementation of change, it is important 
to consider the role of doctors and patients in the perception 
of CV risk. Do doctors know how to accurately assess their 
patients’ CVD risk? Do they communicate this risk to the 
patient? Does the patient understand his or her risk and its 
implications? What is the best way to communicate risk to 
a patient in order to maximize the likelihood of the patient 
understanding that information and acting on it?
This paper reviews and synthesizes the literature around 
doctors’ ability to determine a patient’s risk and the factors 
related to communication of that risk that may influence the 
patient’s understanding of the risk. It also looks at the factors 
that influence patients’ perception of their CV risk and how 
accurately patients understand their risk of CVD. Finally, 
we will discuss the evidence surrounding the most effec-
tive strategies to communicate risk with patients in order to 
maximize the potential impact of such strategies.
Do doctors understand how to 
accurately assess a patient’s risk?
There is now extensive evidence regarding key risk factors 
for CVD and the importance of assessing a patient’s absolute 
CV risk. International guidelines now recommend the incor-
poration of absolute CV risk assessment when assessing and 
treating risk factors. Many tools are now available to estimate 
an individual’s 5- or 10-year absolute risk of coronary disease 
or CVD.4,6,7 However, this information is useful only if it is 
understood by doctors and then communicated accurately 
and effectively to patients.
Studies have shown suboptimal use of such tools in 
primary practice, varying from 17% to 47%.23–26 One 
qualitative study in Australia demonstrated that general 
practitioners (GPs) do not routinely perform absolute CVD 
risk assessments, and when they did, it was primarily for 
education purposes.27 The barriers to effective absolute CVD 
risk assessment identified from the study included lack of 
understanding of the difference between absolute and rela-
tive risk, poor understanding of how to use CVD risk tools 
in clinical management, and lack of incorporation of risk 
tools in practice software. Although some studies show that 
when doctors do use CV risk assessment tools they are not 
always used correctly,28 other research has shown high levels 
of accuracy.29
If GPs are not using risk assessment tools to estimate CV 
risk, how accurate are their estimations? Studies assessing 
the concordance between GPs assessment of CV risk and 
actual patients’ CV risk found that the tendency is for GPs 
to underestimate the patient’s risk.20,30–32 When case reports 
were used instead of actual patients, both overestimation 
and underestimation were seen with more tendency toward 
overestimation.33–38 Little research has been conducted on 
the accuracy of specialists’ assessment of CV risk; however, 
in one study, when cardiologists were shown the same case 
reports as the GPs the former were more accurate regarding 
CVD risk but still tended to overestimate risk.33 Another study 
showed little difference in accuracy between GPs, cardiolo-
gists, and obstetricians/gynecologists.38
Do doctors discuss CV risk  
with their patients?
Several studies report that the general population primarily 
receives their information regarding CVD risk from the 
media.39–41 Media sources of risk, however, can provide only 
general information about a person’s risk. Individualized 
advice about risk should come from a physician; in most 
cases, this will be the patient’s GP. If this is the case, it is 
essential that GPs not only take the opportunity to discuss 
CVD risk when they can but also give accurate advice and 
present it in a way that the patient understands. Australian 
studies have shown that 80% of the population visits their 
doctor in a year, thereby providing an ideal opportunity for 
GPs to discuss CV risk with their patients.42
The barriers to effective estimation and communication 
of CVD risk by GPs have been identified as lack of time 
during the consultation, low patient level of education, and 
low physician level of skill in communicating.43,44
Why is patients’ perception  
of CVD risk important?
Theories surrounding  
health-related behavior
Ideally, in order to prevent CVD, all you would need to do 
is present the general population with information relating 
to their risk of developing CVD including relevant risk 
factors followed by proven risk-factor-reduction strate-
gies. Once given this information, an individual would 
look at it in a rational and logical manner and implement 
the discussed risk reduction strategies, thus minimizing 
his or her CVD risk. However, it is immediately apparent 
that this very rarely happens in reality. The factors that Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
51
Perceived risk of cardiovascular disease
  influence how   individuals understand information and 
use that information to make decisions are many, and the 
decision pathway is complex. Multiple theories have been 
developed to try and explain how people make decisions, 
particularly those related to risk. Ultimately, it is unlikely 
that one theory will explain all decision-making behavior 
due to the complexity of human behavior; however, explo-
ration of some decision-making theories can be helpful in 
understanding why patients do not always make the apparent 
best health-related choices with regard to both prevention 
and treatment. It is also possible to see where perception 
of risk fits into the decision-making pathway with regard 
to heath-related behavior.
Health belief model
The health belief model (HBM)45 was originally developed 
in the 1950s to explain “the widespread failure of people 
to accept disease preventives or screening tests for the 
early detection of asymptomatic disease”. It identifies two 
components that behavior depends on: (1) the desire to avoid 
illness (or if ill, to get well) and (2) the belief that a specific 
heath action will prevent (or ameliorate) illness. The HBM 
consists of four dimensions:
1.  Perceived susceptibility (the subjective perception of risk 
or vulnerability to a health threat)
2.  Perceived severity (an individual’s perception of the 
seriousness of the threat involved)
3.  Perceived benefits (efficacy of an action designed to 
prevent or reduce the threat of an illness)
4.  Perceived barriers (assessment of the negative conse-
quences of undertaking the preventive action)
Also included is the requirement for a “cue to action” 
to start the process that may be internal, eg, symptoms, or 
external, eg, media coverage of a specific disease. It is rec-
ognized that diverse demographic, sociopsychological, and 
other variables may influence the individuals’ perception and 
thereby indirectly influence health-related behavior. Research 
has shown that among the aforementioned dimensions, 
perceived barriers most frequently influences health-related 
behavior, followed by perceived susceptibility, benefits, and 
severity. Other factors are also recognized as contributing to 
decisions regarding health-related behavior such as habitual 
influences, health-related behaviors followed for nonhealth 
reasons (such as dieting to appear more attractive), and also 
economic and environmental factors. This model relies on 
the underlying belief that “health” is a valued commodity and 
that cues to action are prevalent in everyday life. The sus-
ceptibility and severity components mobilize the   individual 
to act, whereas the perceived benefits and barriers are used 
to select a preferred course of action. This model tends to 
view decision making regarding health-related behavior as 
a cognitive process weighing risks and benefits, and does 
not specifically incorporate the impact of feelings on the 
decision-making process; rather, it views feelings as arising 
from the decisions that are made.
Protection motivation theory
The protection motivation theory (PMT)46 is similar to HBM 
in that it places emphasis on cognitive processes mediating 
attitudinal and behavioral change. This theory, however, 
emphasizes that knowledge of an effective behavior is not 
sufficient, the individual must perceive themselves as being 
able to carry it out. This is seen as unrelated to and indepen-
dent of the perceived barriers dimension of the HBM and 
provides the impetus to not only initiate a certain behavior 
but also influence the amount of energy expended and 
persistence despite obstacles. The PMT was developed to 
explain the effects of fear on attitude change. It postulates 
that fear influences attitude and behavior change not directly 
but indirectly by affecting a person’s belief in the severity 
of the threat.
Briefly, PMT suggests that external information such as 
environmental cues or intrapersonal information stimulates 
the individual to initiate a threat appraisal and a coping 
appraisal. The threat appraisal evaluates factors that may 
increase or decrease the likelihood of initiating a certain 
action such as rewards for the behavior (eg, bodily pleasure) 
vs perceived severity of the threat and perceived vulnerability 
of the threat. A coping appraisal involves judgments about 
the efficacy of a preventive response, the perceived ability 
of one to successfully initiate and complete the adaptive 
response and the response costs (eg, inconvenience, expense, 
side effects). The combination of the threat appraisal and the 
coping appraisal forms the protection motivation, which then 
either stimulates or inhibits action. Protection motivation is 
maximized when:
1.  The threat to the individual’s health is severe.
2.  The individual feels vulnerable.
3.  The adaptive response is believed to be an effective means 
of averting the threat.
4.  The person is confident he or she can successfully com-
plete the adaptive response.
5.  Rewards of maladaptive behavior are small.
6.  Costs associated with adaptive behavior are small.
Research in PMT has shown support for the compo-
nents of severity and vulnerability (resulting in behavioral Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
52
Webster and Heeley
intention to, eg, stop smoking or join an exercise program) 
as well as response efficacy and self-efficacy (causing 
  predicted changes in intentions to engage in self-protective 
health behaviors).46
Risk as feelings
An alternative approach to models around health-related 
behavior hypothesizes that response to risk results from 
direct emotional influences.47,48 Action is determined by 
the interplay between cognitive evaluation and feelings at 
the time of decision making, with influence acting in both 
directions. Personal experience also weighs heavily on 
decisions under this model of thought. High levels of fear 
regarding an outcome may lead to defensive avoidance of 
an action rather than embracing the prospect of preventing 
the outcome. It is this emotional influence that may account 
for behavioral responses that do not coincide with an indi-
vidual’s best perceived course of action. Furthermore, fear 
responses tend to be unaffected by changes in probability. 
One determinant of emotional reactions to future outcomes 
is the vividness with which an individual mentally perceives 
the outcome. Other factors that influence reactions include an 
inverse relationship between the time, between the decision 
and the realization of the outcome, and the fear associated 
with the outcome. The effect of an individual’s emotional 
situation at the time of decision making increases in influ-
ence as time for analysis decreases.48
Also of importance in this theory is the idea that patients 
base judgments of an activity not only on what they think 
about it but also on how they feel about it. This means feelings 
direct the judgment of risk and benefit. If they feel favorably 
about an activity then they are likely to judge the risks as low 
and the benefits as high, and vice versa.
Unrealistic optimism
Despite the different theories surrounding the determinants 
of health-related behavior, each theory incorporates at some 
point the concept of the individual’s perception of his or her 
personal risk related to an activity or a disease state. It drives 
decision making as one of the determinants or is modified 
by or influences feelings. In this context, it is important 
to determine whether patients are realistic about their risk 
perception associated with particular conditions as this will 
contribute to the likelihood of patients adopting appropriate 
behaviors to reduce their risk.
Weinstein’s work in the 1980s introduced the concept of 
most peoples’ “unrealistic optimism” related to their vulner-
ability to a range of health issues.49–51 Weinstein interviewed 
college students regarding their perceived vulnerability to 
a wide range of health issues compared to their peers.49 
Optimistic bias was defined as the majority of students 
indicating that the students considered themselves to be at a 
lower risk of developing a certain health issue compared to 
one of their peers. They showed a significant optimistic bias 
related to their risk for most health issues with the amount 
of bias varying greatly. Unrealistic optimism increased with 
perceived controllability of the issue or if they perceived an 
issue as something that would have already developed in 
them if it was going to affect them. Interest in taking steps 
to decrease their risk were correlated with worry, recogni-
tion of risk factors for the condition, perceived seriousness 
of the condition, mental image of the condition, heritability 
of the condition and environment. Weinstein concluded that 
the data collected was consistent with the belief of general 
population being concerned with “self-esteem enhance-
ment”, ie, we believe that we are inherently healthier than 
others or that our self-protective actions are more extensive 
or effective than those of others. Patients also tend to give 
themselves credit for self-protective factors in their life but 
fail to give similar credit to actions or behaviors associated 
with higher risk. Subjects in his study were also more realis-
tic about factors that were unlikely to harm their self-esteem, 
eg, hereditary or environmental factors. The impact of this 
“optimistic bias” was that it reduced the motivation to take 
precautions to avoid the risk.
In order to expand the generalizability of his research, 
Weinstein further surveyed 296 members of the general 
community about their perceived health risks.51 He found 
that optimistic bias was not limited to any particular age, 
sex, educational, or occupational group. He also confirmed 
that this tendency to optimistic bias increased with perceived 
preventability of the condition, perceived embarrassment 
associated with the condition, and belief of exemption if the 
condition had not already appeared. Decreased optimistic 
bias was associated with experience with the health condi-
tion, and the perceived frequency and the perceived extent 
of others in the community worrying about it.
Regarding CVD, Weinstein’s work around the concept 
of optimistic bias predicts that majority of the population is 
unrealistic about their CVD risk.
Patients’ perception  
of their CVD risk
General population
Several studies have investigated the correlation between 
patients’ perceived risk of CVD and their actual calculated Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
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risk based on epidemiological data. It appears that patients are 
generally inaccurate in their estimates and the bias tends to 
be toward inappropriate optimism. This has been confirmed 
in many different populations and by both qualitative and 
quantitative research.
Three studies have shown that about 40% of the general 
population underestimates their CV risk,52–54 with approxi-
mately 20% overestimating their risk. Although van der 
Weijden55 showed similar results for overestimation of risk 
(18%), she found that only 15% underestimated their risk. 
The reason for this discrepancy in risk underestimation was 
unclear.
Interestingly, the study by Christian et al56 showed 
slightly different results with 71% of mainly ethnic women 
at medium–high risk of CVD having an accurate understand-
ing of their risk but only 52% of low-risk women accurately 
identifying their low-risk status (ie, 29% underestimating 
and 48% overestimating their risk). The study by Frijling57 
showed similar results with 68% of patients overestimating 
their risk for a heart attack and 30% underestimating their 
risk; results were similar for stroke. In Frijling’s study, 
hypertensive or diabetic patients were asked to place their 
estimated risk on a numerical gauge from 0% to 100%, 
compared to most other studies that used Likert scales 
for estimating relative risk. Interviews with “blue-collar” 
workers41 revealed that although some saw risk factors as 
influencing risk, others saw it as “luck of the draw”. The 
behaviors shown to be effective in reducing risk were found 
to be in direct competition with those perceived as enhancing 
the quality of life, thus impacting the likelihood of patients 
adopting such activities.
Risk awareness in women
Mosca and colleagues have undertaken significant research 
into American women’s awareness of CV risk, barriers to 
understanding risk, and implementation of preventive activi-
ties. A total of five cross-sectional surveys were conducted 
between 1997 and 200939,58–61 on women older than 25 years 
who answered questions regarding their awareness, knowl-
edge, and perceptions of CVD risk and prevention.
In the 2009 survey,39 54% of women correctly identified 
heart disease as the main cause of death in women, which had 
increased from 30% in 1997. This 54% included a tripling 
of awareness in black women and a doubling in white and 
Hispanic women although ethnic minorities were still less 
aware than white women. About 45% of surveyed women 
considered themselves to be well-informed about heart 
disease. Although 56% cited chest, neck, shoulder, and arm 
pain as a symptom of heart disease, a considerably lesser 
number (7%–29%) identified less well-known symptoms 
such as shortness of breath, chest tightness, nausea, and 
fatigue. Only 53% said they would call an ambulance if they 
thought they were having a heart attack; 25% would take 
an aspirin. Top prevention strategies were listed as getting 
adequate sleep, regular fish oil/omega-3 fatty acids, and 
taking aspirin. A matter of concern was that 60%–70% of 
women thought that taking antioxidants or special vitamins 
(eg, A, C, E) would help prevent heart disease. While 45% 
cited television as their main source of information, 32% cited 
magazines, 18% the newspaper, and 14% the Internet. Of 
the women surveyed, 48% reported discussing heart disease 
with their doctor. The majority of women had taken some 
preventive actions in the previous year such as checking their 
blood pressure (84%), trying to manage stress better (74%), 
and going to see a doctor or other health professional (73%). 
Reported barriers to taking preventive action included family/
care-giving responsibilities (51%) and too much confusion in 
the media about what to do (42%). The main motivators for 
taking preventive action were reported as wanting to improve 
their health, and feel better or live longer.
These cross-sectional studies give an insight into progress 
related to the effects of education regarding heart disease 
in the US. Despite mass media campaigns and widespread 
information dissemination, the majority of American women 
do not understand heart disease in much detail; there is also 
a lack of understanding of important preventive strategies. 
These findings are likely to be applicable to other countries 
as a National Heart Foundation of Australia cross-sectional 
survey of 3,500 Australians in the year 2009 reported that 
only around 20% of women knew that CVD was the leading 
cause of mortality for women and that they felt more threat-
ened by breast cancer, despite the fact that mortality from 
heart disease is 4 times higher (personal written communica-
tion, June 9th, 2010). In contrast to men, women are more 
likely to consider factors such as stress as significant risk 
factors62 and they see themselves at risk only after reaching 
menopause.63
High-risk populations
Estimation of risk has also been studied in selected 
populations with established high risk of CVD. In a popula-
tion-based study of 1,253 patients at high risk of stroke, only 
41% were aware of their increased stroke risk (only 42% 
of those who had already had a stroke were aware of their 
increased risk for a subsequent stroke).64 It was found that 
79 patients discharged following treatment for heart attack Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
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showed no correlation between their perceived risk of another 
heart attack and their TIMI scores (a measure of risk post 
heart attack).65 A small study of 20 patients with diabetes 
showed that only 7 considered diabetes as a risk factor for 
CVD.66 Strecher et al67 evaluated whether smokers had a 
more realistic perception of their CVD risk than nonsmok-
ers and found that although smokers were more likely to 
perceive themselves as at a higher risk of heart attack and 
stroke, they were still more likely than nonsmokers to have 
optimistic bias.
Since it is has been suggested that having obvious CVD risk 
factors does not necessarily improve an individual’s estimation 
of risk, it is worth taking a look at what influences how patients 
think about their risk and what factors have been shown to be 
associated with an inaccurate estimation of risk.
Why don’t patients have  
an accurate understanding  
of their risk?
General factors
Patients generally have insufficient knowledge about CVD 
or CV risk factors55,68 and often tend to have a dichotomous 
understanding of risk rather than understanding risk as a con-
tinuum. They also tend to compare themselves to patients who 
are worse off than themselves when judging their personal risk 
rather than another average person like themselves.
Older age,52,57,69 smoking,52,55,57,67,70 family history,52,53,57,69 
the presence of typical CV risk factors,52,53,69 including 
obesity53,55,70 and high blood pressure,55,69 and higher edu-
cation level52 have all been shown to increase a person’s 
perceived risk of CVD, which is likely to decrease the 
occurrence of optimistic bias. When accuracy of estima-
tion of risk was specifically tested, older age,56,64 smoking,54 
male sex,57–67 the presence of typical CV risk factors,64 
including obesity54 and high blood pressure,54 and higher 
education level were all shown to increase the accuracy of 
estimated risk.54,67
Interestingly, other studies have shown that older age40,54,67 
and male sex40,54,55 have in fact led to a decreased accuracy 
in estimation of risk.
In qualitative studies asking patients about what they 
perceive to be the most important risk factors for CVD, 
stress,41,66,71 smoking,41,53 and family history53,66,71 recurred 
as common themes rather than cholesterol and blood 
pressure. This has important implications when it comes 
to communicating risk to patients as doctors may discuss 
cholesterol and blood pressure even though the patient does 
not consider these issues to be particularly important when 
it comes to CV risk.
Health literacy and numeracy
Increasingly, it is recognized that in order to understand 
health-related information, patients must have a certain level 
of health literacy and numeracy.
Health literacy can been defined as “a constellation of 
skills, including the ability to perform basic reading and 
numerical tasks required to function in the health care 
environment”.72 It has three levels:73
1.  Basic/functional literacy (ie, basic reading and writing 
skills enabling a person to function effectively in everyday 
situations)
2.  Communicative/interactive literacy (more advanced 
cognitive and literary skills that can be used to actively 
extract information, derive meaning from different forms 
of communication, and apply this meaning to changing 
circumstances)
3.  Critical literacy (more advanced skills that can be used to 
critically analyze information and to exert greater control 
over life events and situation)
A key component of health literacy is numeracy, which 
in its broadest sense is the ability to understand and use 
numbers. Within this definition, however, are included 
more complex concepts such as the ability to perform 
simple arithmetic operations; compare magnitudes; and 
understand ratio concepts including fractions, propor-
tions, percentages, and probabilities.74 A person’s level of 
health literacy impacts many facets of health care including 
reading and understanding health literature, understanding 
medication labels and instructions, and keeping track of 
appointments. Level of numeracy is even more essential in 
the context of accurate risk perception as this requires the 
ability to assess risk magnitude, compare risks, and under-
stand decimals, fractions, percentages, probabilities, and 
frequencies.74 Poor health literacy and numeracy is wide-
spread but often not recognized. The proportion of patients 
with limited health literacy has been shown to be between 
34% and 59% (primarily US data)75 with low numeracy 
shown to be associated with self-reported poor health, 
health disparities, poor health knowledge, poor disease 
self-management skills, and choice of lower-quality health 
options.76 The financial costs associated with low health 
literacy have been estimated as 3%–5% of total health 
costs.75
One reason why poor health literacy impacts patients’ 
understanding of CVD is that it has been shown that historically Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
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education material related to CVD is written at an inappropri-
ate reading level.77 Most medical professionals rely on written 
materials to supplement their own education strategies in order 
to maximize the amount of information that can be given to 
patients; however, if those patients do not understand the 
literature and are too embarrassed to admit this (as is likely), 
there is no point handing the information out. Unfortunately, 
studies have shown that not only do physicians not understand 
the issue of health literacy or the level at which information 
needs to be given but they are also very poor at judging the 
health literacy or the numeracy ability of their patients.77 This 
lack of awareness and therefore lack of addressing the issue 
adds an extra layer of complexity to the reasons surrounding 
patients’ poor perception of their CVD risk.
In the year 2005, the national cholesterol education pro-
gram, an initiative of the National Heart, Lung, and Blood 
Institute (NHLBI) in the US, launched their national choles-
terol education month with the slogan, “know your cholesterol 
numbers, know your risk”. Considering the low numeracy 
identified in the US, it is unsurprising that this slogan was not 
recognized or found to be compelling by focus groups.55,68
What strategies are recommended 
to maximize the chances 
of communicating risk  
effectively to patients?
If accurate perception of risk by both patients and doctors 
is necessary in order to maximize the chance of the patient 
taking appropriate actions to reduce their risk, then it is 
important to recognize what strategies are most likely to 
improve perception of risk. However, it is also important 
to recognize the potential of information being manipulated 
using these strategies in order to coerce patients into adopting 
the physician’s preferred course of action rather than help 
the patient decide within their own value system and life 
situation their preferred course of action. The intention is to 
aid the patient and the doctor to accurately understand the 
risk and not to manipulate their decision to suit a third party. 
Physicians should be aware framing is one such tool that may 
have the aforementioned effect.
The effect of framing
When options are presented to a patient for most health-re-
lated actions, several reviews have confirmed that patients are 
more likely to take up a recommended action when the ben-
efits are presented as relative risk reduction (RRR) compared 
to absolute risk reduction (ARR) or number needed to treat 
(NNT).78–80 It is possible that this is due to patients not com-
prehending the difference between a relative change and an 
absolute change. The larger apparent benefit communicated 
in RRR may be more attractive than the smaller apparent 
benefit discussed in ARR and NNT. This difference, how-
ever, is modified in studies where baseline risk information 
was given and it has been considered that some of the larger 
differences seen may be due to methodological problems in 
the studies where it was not made clear in the intervention 
whether the risk reduction was absolute or relative (eg, is the 
statement “death was reduced by 20% in the intervention 
group” referring to an ARR or RRR?).
Similarly, when discussing screening, patients tend to 
be more responsive when the disadvantages of not being 
screened (loss framing) rather than the advantages of being 
screened are discussed.79
Physicians have also been shown to be affected by framing 
of information with the same responses shown by patients. 
When results are shown as RRR, rather than ARR or NNT, phy-
sicians are more likely to treat a patient. This was sometimes 
modified or nullified by risk aversion, physician experience, 
level and type of risk, clinical situation, beliefs about treatment 
efficacy, and costs of treatment.81 A limiting factor in this 
research is that studies have been carried out using scenarios 
and hence the effect on clinical practice is unknown.
One example of this concept in practice is as follows: 
pharmaceutical companies, when advertising their products, 
tend to use RRR as their method of communication. Although 
ARR or NNT may be included in the original research, the 
marketing information will almost always mention RRR. 
These companies are obviously aware that research has 
shown more people respond to RRR than other forms of risk 
communication. This is particularly relevant in countries 
where pharmaceutical companies are allowed to market 
directly to the consumer (such as the US); patients may then 
approach their doctor demanding treatment that may not 
be indicated, recommended, or as beneficial as the patient 
believes. If the doctor also does not fully understand the 
statistics presented by such companies then patients may 
end up inappropriately treated.
Incomplete understanding of RRR vs ARR or NNT can 
be used to manipulate behavior by deliberately utilizing one 
statistic over another without providing all the information 
necessary to make a balanced decision. This can affect the 
decisions of both doctors and patients as both groups have 
been shown to be affected by framing. Deliberately utilizing 
this type of manipulation in the doctor–patient relation-
ship could be seen as nullifying the “informed consent” Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
56
Webster and Heeley
part of treatment discussion although some may argue that a 
paternalistic attitude in presenting information is justified when 
the patient’s best interests are central to the motivation.
Fear appeals
Communicating information in a way that instills fear in the 
recipient can be highly effective in convincing a person to do 
something or not do something.82 This principle has been used 
in many health-related advertising campaigns, particularly 
those aimed at smoking and the use of sunscreen. Fear appeals 
have been shown to motivate attitude, intention, and behavior 
changes especially when accompanied by high-efficacy mes-
sages, and therefore they can be useful to doctors.82 However, 
this approach can backfire if the person hearing the message 
does not believe they can effectively avert the threat; in these 
cases, it can lead to a defensive denial response.82
General evidence-based tools 
for communicating evidence
Any communication tool is better than nothing for improving 
knowledge about health care.83 The more structured, tailored, 
and interactive the method of communicating evidence, the 
greater the resulting level of knowledge and understand-
ing in patients. Training for health care professionals in 
patient-centered approaches has also been shown to be 
effective in increasing the patient’s level of understanding 
the evidence.
Decision aids (any intervention designed to help 
patients make specific and deliberative choices among 
options by providing information on the options and the 
outcomes relevant to a person’s health status and implicit 
methods to clarify values) have been shown to result in:84
1.  Greater knowledge
2.  Lower decisional conflict related to feeling uninformed
3.  Lower decisional conflict related to feeling unclear about 
personal values
4.  Reduced proportion of patients who were passive in deci-
sion making
5.  Reduced proportion of patients who remained undecided 
postintervention
6.  More accurate risk perception (if probabilities were included 
in the decision aid) with better accuracy if the probabilities 
were presented quantitatively rather than qualitatively
Communication of risk
A recent systematic review showed that repeatedly provid-
ing patients with global coronary heart disease (CHD) risk 
education alone or with accompanying education increased the 
patient’s accuracy of risk perception and probably increased 
intent to start therapy. Studies utilizing this type of intervention 
showed small significant reductions in predicted CHD risk 
(absolute differences of −0.2% to 2% older than 10 years).85
Generally, when communicating risk, it is recommended 
to use simple numbers (not log scales) with clear explana-
tions where there is no requirement for the patient to per-
form their own calculations.86 Patients have a more accurate 
perception of risk when it is communicated in numerical 
rather than descriptive (such as “a small chance”, “not very 
likely”, “very likely”) format.83,84,87 When using numerical 
format, it is important to be consistent with the type of sta-
tistic being used (ie, percentage, natural frequencies, relative 
risk) and also the denominator so that the patient can compare 
apples with apples.86–88 When presenting relative risk, patients 
are likely to overestimate the risk and therefore a baseline 
value needs to be provided as well to provide a reference 
point.83,86 When presenting information, it is also important 
to provide an interpretative standard or threshold, if possible, 
in order to aid understanding (eg, above/below average) and 
also to personalize the risk to the individual.86
Use of visual aids such as graphs, icons, and illustrations 
can be helpful in increasing the understanding of a particular 
concept.83,86,87 Large amounts of data can be summarized in 
a graph or other type of figure, but it must be remembered 
that some graphs can be highly complex or confusing and 
therefore can lead to confusion in the patient.86 It is important 
to use the appropriate graph for a specific purpose and always 
provide clear, comprehensible explanations of the graph. The 
downside of graphs or other visual cues can be that they may 
be more time consuming to prepare, particularly in the case 
of an individual’s CVD risk. Availability of CVD risk calcula-
tors built into practice software is widespread in developed 
countries; however, this may be an issue elsewhere.
Communicating other specific characteristics of risk 
such as multiplicative risk, cumulative risk, and also small 
probabilities requires more specific strategies; however, little 
research has been done on the optimal way to communicate 
such characteristics.86
In addition to the practical aspects of how to enable a 
patient to understand the numbers associated with their CVD 
risk, it is also important that the patient trust the doctor; 
otherwise, patients are unlikely to believe what the doctors 
are saying or take action based on their recommendations.87,89 
Paling87 suggests that striving for both competence and a 
caring approach in the consultation is imperative to instilling 
trust in a patient.Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
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One novel strategy that was developed to try and over-
come the problem of low health literacy in the general 
population was a primer that aimed at improving patients’ 
medical data interpretation skills.90 It was written in a lan-
guage suitable for patients aged 14 years or younger, and in 
randomized trials conducted in both low and high socioeco-
nomic groups it improved medical interpretation scores and 
also interest in medical statistics. Participants in the trials 
rated the primer highly and spent quite a bit of time reading 
it although this did not increase the patients’ confidence in 
interpreting statistics outside the primer. However, this type 
of intervention is essential in attempting to overcome the 
significant hurdle of low health literacy and numeracy.
Patient preferences for type of visual aid
Few qualitative studies have been conducted that aim at 
eliciting patients’ preferred format for receiving risk informa-
tion. Graphical formats (particularly bar charts) have been 
perceived as helpful in some studies but not in others68,91(Hill, 
unpublished data). Thermometer scales, with percentages 
and strong use of color to demonstrate comparative risk, 
were also preferred in one study (Hill, unpublished data). 
Two studies showed a preference for risk to be presented in 
absolute terms rather than relative risk.68,91
internet
Delivery of health information via computer has also been 
shown to increase efficacy,92 Widespread community access to 
the Internet93 and the increasing use of the Internet as a source 
of information related to health94 provides a novel opportunity 
for low-cost, Internet-based, community-mediated health care 
delivery. Previous studies have shown that highly interactive 
health communications applications that allow multiple inter-
actions with participants over time may have a positive effect 
on knowledge sharing and social support with some evidence 
of improved behavioral and clinical outcomes in patients 
with chronic diseases.95 There is also some evidence that such 
applications can positively influence behaviors related to CV 
risk such as nutrition and physical activity.96
In the field of CV prevention, the provision of tailored 
behavior change messages has been shown to enhance uptake 
of information compared to simple provision of health risk 
information,97 and there exist some websites offering such 
tailored advice directed at the consumer.98,99 Unfortunately, 
these websites tend to be simple, without the highly interac-
tive features that have been shown to be effective in changing 
behavior. To make available a cheap, simple webpage that 
provides consumers with information is unlikely to make a 
serious impact on patients’ CVD risk prevention practices. 
What is needed is investment in high-quality, easily acces-
sible, highly interactive websites containing tailored advice 
specific to a patient.
improving doctors’ assessment 
of CvD risk
Underlying the aforementioned recommendations for 
enhancing patients’ understanding of their risk is the necessity 
for health care professionals to understand how to calculate 
absolute risk and change their practice to routinely calculate 
absolute CVD risk for their patients. Systematic review of 
strategies to improve doctors’ utilization of CVD risk tables 
showed no clear relationship between any particular strategy 
and the uptake of CVD risk tables; however, promising 
strategies seemed to be those involving teamwork, nurse-led 
clinics, and integrated information technology (IT) support 
(eg, computerized decision support). Recommendations 
included the need to support physicians in identifying high-
risk patients (possibly through integrated computerized deci-
sion support or invitation letters to patients in their practice 
to attend for review), completing the risk profile (this could 
be achieved via an integrated computerized decision support 
tool), calculating the risk (in order to address the documented 
failure of many physicians to accurately use these risk calcu-
lators), communicating risk (possibly by increased education 
regarding communication strategies), and deciding jointly 
with the patient on appropriate management of their risk.
Such a computerized decision support tool that populates 
itself with data from the patient’s electronic record, calculates 
CVD risk, and presents the doctor with specific treatment 
advice based on current guidelines has been developed in 
Australia.100 Widespread availability of such a tool has the 
potential to address many of the identified barriers to accurate 
perception of CVD risk by doctors.
Conclusion
In most cases, CVD is a preventable disease. However, 
the opportunity to prevent it is not being taken up by large 
numbers of patients. Accuracy of patients’ perception of the 
level of their CVD risk is essential in the prevention of CVD 
(especially for those at the highest risk level) as it will help 
stimulate the adoption of preventive actions and activities. 
Many factors contribute to a person’s understanding of his 
or her CVD risk. Accuracy of information given to patients 
and their ability to understand that information are impor-
tant, but individuals are also influenced by social context, 
emotional state, and other lifestyle factors such as work or Risk Management and Healthcare Policy 2010:3 submit your manuscript | www.dovepress.com
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caring responsibilities. Anecdotal experience from a person’s 
family or social group cannot be underestimated either.41
Generally, patients do not have an accurate idea of their CVD 
risk and unfortunately this predominantly results in underesti-
mation of risk. A matter of perhaps more concern is that GPs, 
who are perfectly positioned to provide information to patients 
and correct their misperceptions about CVD prevention, are 
also likely to underestimate the patients risk resulting in missed 
opportunities to educate patients, treat CVD, and ultimately 
prevent CVD. In order to correct patients’ understanding of their 
risk, the accuracy of doctors’ understanding of CVD risk needs 
to be improved and they need to be educated further in proven 
effective means to communicate risk to their patients.
Advancement in understanding the role of CVD risk, the 
multiplicative nature of risk factors, and how to calculate a 
person’s CVD risk has overtaken many GPs’ knowledge in 
this area. The GPs need to comprehend the extent of low 
numeracy and literacy in the population and take this into 
consideration when providing health-related information. 
Further education is required to remedy this issue both 
at a medical school level and the level of those already 
established in practice. Aids to help GPs must take into 
account short consultation times because often attention 
on a patient’s CVD risk will need to be opportunistic and 
dealt with at the end of a consultation related to another 
medical problem.
Further research is needed specifically in the area of com-
municating CVD risk, including development of standard-
ized tools that have been shown to be effective not only in 
communicating risk but also in changing practice that GPs 
can use to communicate with their patients. Regular training 
opportunities will aid in upskilling to enhance accurate com-
munication of risk.
Development of novel strategies such as electronic decision 
support tools linked to electronic health records may help GPs 
in calculating risk and provide them with visual tools such as 
graphs to help in communicating this risk to patients.
Although CVD is preventable, it can be prevented only if 
patients have an accurate perception of their risk of CVD. It 
is the responsibility of doctors and other health professionals 
to continue to work to bridge this gap.
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